Cn /En

News Center

——

Company news

Industry news

Analysis of the technical features of the iHuPBMC-B platform of InnoModels Biotechnology

Author:

InnoModels

Release time:

2024-08-23

At the forefront of biomedical research, especially in the fields of tumor immunity, autoimmune diseases, and vaccine development, an efficient and accurate animal model system is crucial for promoting scientific research and technological innovation. With its self-developed iHuPBMC-B platform, InnoModels Biotechnology provides a revolutionary solution for researchers in these fields. This article will introduce the core technical features of iHuPBMC-B platform in detail.
1. Innovative Humanized B Cell Reconstruction Technology
The core advantage of iHuPBMC-B platform lies in its innovative humanized B cell reconstruction technology. This technology has successfully introduced B cells from human peripheral blood mononuclear cells (PBMC) into immunodeficient mice, realizing efficient reconstruction and stable expression of B cells. This breakthrough not only retains the advantages of easy operation and lower cost of the PBMC model, but also overcomes the limitation of the lack of function of human B cells in the traditional model, providing a more realistic and complete simulation environment for the study of human immune response.
2、Simulate the real humoral immune process
The iHuPBMC-B platform is capable of simulating the complete humoral immune process from antigen recognition, B cell activation, antibody generation to effector play. This high level of simulation capability enables researchers to observe human-like immune responses in the laboratory, thus more accurately assessing the efficacy, mechanism and safety of immunotherapy. In addition, the platform has the ability to parse complex immune networks, helping to reveal key molecules and signaling pathways in immune responses.
3. High reconstruction efficiency and stability
Compared with traditional humanized animal models, the iHuPBMC-B platform excels in reconstruction efficiency and stability. The platform adopts advanced cell culture technology and optimized mouse strains, which significantly improves the reconstruction success rate of B cells and ensures the stability of the model in a long period of time. This high efficiency and stability makes the iHuPBMC-B platform an indispensable tool in biomedical research.

4. Wide application potential
The iHuPBMC-B platform has a wide range of application potentials, covering tumor immunity, autoimmune diseases, infectious diseases and vaccine development. In tumor immunity research, the platform can be used to assess the immunogenicity of tumor vaccines, the efficacy of immunotherapy, and the immunoregulatory mechanism of the tumor microenvironment; in autoimmune disease research, it can be used to explore the immunopathological mechanism of disease development and the development of new therapeutic methods; in infectious disease research, it can be used to study the interaction between pathogens and the host immune system as well as the protective effect of vaccines. V. Provide customized services
5、Provide customized services
InnoModels Biotechnology understands the uniqueness and individual needs of each research project. Therefore, iHuPBMC-B platform not only provides standardized technical solutions, but also customized services for customers. From experimental design, model building to data analysis, the expert team of InnoModels Biotechnology will be involved in the whole process to ensure that the customer's research project can be carried out smoothly and achieve the expected results.
6、Promote the development of biomedical research
The emergence of iHuPBMC-B platform has undoubtedly injected new vitality into biomedical research. With its unique technical features and wide application potential, it provides researchers with a powerful tool to promote the rapid development of tumor immunity, autoimmune diseases, and vaccine research and development. In the future, with the continuous progress and improvement of the technology, the iHuPBMC-B platform is expected to play an important role in more fields and make greater contributions to human health.

Introduction to the SCID Mouse NK Efficacy Model of InnoModels Biotechnology

Technical Features of the iHuPBMC-NK Platform from InnoModels Biotechnology

Introduction to the SCID Mouse NK Efficacy Model of InnoModels Biotechnology

Technical Features of the iHuPBMC-NK Platform from InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License